Stock listing
PGEN Stock Price, News, Filings & Events — Precigen, Inc.
Selected listing: PGEN · NASDAQ · USD · US
This page tracks Precigen, Inc.'s PGEN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PGEN:NASDAQ. PGEN:NASDAQ is the stock-level entry point for investors researching Precigen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precigen, Inc. is a public company traded under the ticker PGEN in the American market. With a market capitalization of approximately $1.93 billion, Precigen focuses on advancing innovative gene and cell therapies. The company's mission is to transform the treatment of diseases through its proprietary technologies and research initiatives.
- Ticker
- PGEN:NASDAQ
- Asset type
- Stock
- Market cap
- $2.49B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Precigen, Inc. PGEN:NASDAQ stock context
This page tracks Precigen, Inc.'s PGEN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following PGEN:NASDAQ. PGEN:NASDAQ is the stock-level entry point for investors researching Precigen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Precigen, Inc. is a public company traded under the ticker PGEN in the American market. With a market capitalization of approximately $1.93 billion, Precigen focuses on advancing innovative gene and cell therapies. The company's mission is to transform the treatment of diseases through its proprietary technologies and research initiatives.
Latest news from Precigen, Inc.
Precigen Reports Second Quarter 2026 Financial Results Highlighted by Accelerating PAPZIMEOS Revenue Growth
August 4, 2026
Precigen to Announce Second Quarter 2026 Financial Results and Provide Business Updates on August 4
July 21, 2026
Precigen Gains Advantage as PAPZIMEOS Granted Orphan Drug Exclusivity by FDA; Long-Term Data From Clinical Study Encouraging
June 15, 2026
Precigen and the Recurrent Respiratory Papillomatosis Foundation Recognize International RRP Awareness Day by Elevating Patient and Commu...
June 11, 2026
Precigen Presents New Long-Term Durability Data for PAPZIMEOS, Recently Granted Seven-Year Market Exclusivity, Demonstrating Complete Res...
May 30, 2026
Precigen, Inc. earnings calls
Precigen, Inc. (PGEN) Q2 2026 Earnings Call
August 4, 2026 · Replay with transcript and chapters
Precigen, Inc. (PGEN) Q1 2026 Earnings Call
May 13, 2026 · Replay with transcript and chapters
Precigen, Inc. (PGEN) Q4 2025 Earnings Call
March 25, 2026 · Replay with transcript and chapters
Precigen, Inc. (PGEN) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Precigen, Inc. (PGEN) Q4 2024 Earnings Call
March 19, 2025 · Replay with transcript and chapters
Precigen, Inc. (PGEN) Q2 2024 Earnings Call
August 14, 2024 · Replay with transcript and chapters
Research Precigen, Inc.
Precigen, Inc. investor report
Review AI stock analysis and investor report context for PGEN:NASDAQ.
Precigen, Inc. company profile
View the public company page for Precigen, Inc. on 6ix.
Precigen, Inc. news
Read company news and market updates connected to Precigen, Inc..
Precigen, Inc. investor events
Find investor webinars, events, and replay context for Precigen, Inc..
Alternate listings
I5X:GETTEX
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
A2PZG1:LS
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
A2PZG1:LSX
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
I5X:TRADEGATE
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
PGEN:BOATS
US · USD
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
I5X:FWB
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
I5X:BX
CH · CHF
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
I5X:DUS
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
I5X:HAM
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
I5X:MUN
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.
I5X:SWB
DE · EUR
Alternate listing for Precigen, Inc.; the primary context on this page is PGEN:NASDAQ.